Odyssey Health (ODYY) EBIT (2014 - 2026)
Odyssey Health's (ODYY) quarterly EBIT came in at -$297554.0 in Q2 2026, down 130.56% year-on-year from $973553.2 in Q2 2025, and down 63.54% quarter-over-quarter from -$181942.0 in Q1 2026.
Odyssey Health (ODYY) EBIT (2014 - 2026) Analysis & Trends
Odyssey Health's EBIT history runs 13 years deep, the most recent figure standing at -$297554.0 for Q2 2026.
- On a quarterly basis, EBIT fell 130.56% year-over-year to -$297554.0 in Q2 2026; TTM through Apr 2026 was -$938364.0, a 49.51% decrease from a year earlier, with the FY2025 full-year figure at -$1.0 million, up 52.29% from the prior year.
- EBIT slipped to -$297554.0 in Q2 2026 per ODYY's latest filing, from -$181942.0 in the prior quarter.
- Across five years, EBIT topped out at $237431.0 in Q3 2024 and bottomed at -$2.9 million in Q2 2022.
- The 5-year median for EBIT is -$475899.0 (2024), against an average of -$857458.5.
- Across the five-year window, EBIT slumped 211.77% in 2022 and surged 136.24% in 2024, its largest moves.
- Year by year, EBIT stood at -$2.1 million in 2022, then soared by 83.29% to -$347239.0 in 2023, then tumbled by 66.87% to -$579427.0 in 2024, then surged by 47.67% to -$303190.0 in 2025, then gained by 1.86% to -$297554.0 in 2026.
- Per Business Quant, the three latest ODYY EBIT figures stand at -$297554.0 (Q2 2026), -$181942.0 (Q1 2026), and -$303190.0 (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -297,554.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -297,554.00 |
| Jan 31, 2026 | -181,942.00 |
| Oct 31, 2025 | -303,190.00 |
| Jul 31, 2025 | -155,678.00 |
| Apr 30, 2025 | -129,055.00 |
| Jan 31, 2025 | -156,593.00 |
| Oct 31, 2024 | -579,427.00 |
| Jul 31, 2024 | 237,431.00 |
| Apr 30, 2024 | -372,371.00 |
| Jan 31, 2024 | -1.16 Mn |
| Oct 31, 2023 | -347,239.00 |
| Jul 31, 2023 | -655,108.00 |
| Apr 30, 2023 | -1.09 Mn |
| Jan 31, 2023 | -1.49 Mn |
| Oct 31, 2022 | -2.08 Mn |
| Jul 31, 2022 | -1.83 Mn |
| Apr 30, 2022 | -2.87 Mn |
| Jan 31, 2022 | -1.98 Mn |
| Oct 31, 2021 | -1.43 Mn |
| Jul 31, 2021 | -2.61 Mn |